• FirefoxInstall the new Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.27%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    8.32 Up 0.15(1.84%) 12:32PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:8.17
    Open:8.24
    Bid:8.31 x 3500
    Ask:8.32 x 2400
    1y Target Est:8.35
    Beta:1.22
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:8.17 - 8.41
    52wk Range:4.90 - 9.19
    Volume:2,814,576
    Avg Vol (3m):6,177,060
    Market Cap:1.56B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 1.84%1.56B
    NVSUp 0.81%240.75B
    PFEUp 0.79%211.02B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.04
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback